Cargando…
A Close Look at the Clinical Efficacy of Rho-Associated Protein Kinase Inhibitor Eye Drops for Fuchs Endothelial Corneal Dystrophy
The current understanding on the clinical efficacy of Rho-associated protein kinase (ROCK) inhibitor for treating Fuchs endothelial corneal dystrophy is summarized to clarify whether the “off-label” ROCK-inhibitor eye-drop application are appropriate. ROCK-inhibitor eye drops may eventually be deeme...
Autores principales: | Kinoshita, Shigeru, Colby, Kathryn A., Kruse, Friedrich E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cornea
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423139/ https://www.ncbi.nlm.nih.gov/pubmed/34481406 http://dx.doi.org/10.1097/ICO.0000000000002642 |
Ejemplares similares
-
Update on the Surgical Management of Fuchs Endothelial Corneal Dystrophy
por: Blitzer, Andrea L., et al.
Publicado: (2020) -
Combined Photorefractive Keratectomy and Corneal Cross-Linking for Keratoconus and Ectasia: The Athens Protocol
por: Kanellopoulos, Anastasios John
Publicado: (2023) -
Feasibility of cell-based therapy combined with descemetorhexis for treating Fuchs endothelial corneal dystrophy in rabbit model
por: Okumura, Naoki, et al.
Publicado: (2018) -
Transcorneal freezing and topical Rho-kinase inhibitor treatment in Fuchs endothelial corneal dystrophy
por: Menzel-Severing, Johannes, et al.
Publicado: (2021) -
Corneal Hydration Control in Fuchs' Endothelial Corneal Dystrophy
por: Wacker, Katrin, et al.
Publicado: (2016)